Paperpal Prime Logo

Artificial Cells, Nanomedicine and Biotechnology : Impact Factor & More

eISSN: 2169-141XpISSN: 2169-1401
JournalOpen Access

Key Metrics

CiteScore
13.6
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Biotechnology
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Artificial Cells, Nanomedicine and Biotechnology

Artificial Cells, Nanomedicine and Biotechnology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Continuous publication
Article Processing ChargesGBP 2085
Publication Time20
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Artificial Cells, Nanomedicine and Biotechnology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Artificial Cells, Nanomedicine and Biotechnology

Mechanism by which Qingre Lishi formula regulates Behçet’s disease through gut microbiota-derived metabolites
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Green synthesis of ZnO nanoparticles using pomegranate husk extract: comparative evaluation of antioxidant, enzyme inhibition, and cytotoxic properties
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Anticancer activity of fluoxetine Janus dendrimer against cancer cells
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Mechanism by which Qingre Lishi formula regulates Behçet’s disease through gut microbiota-derived metabolites
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Green synthesis of ZnO nanoparticles using pomegranate husk extract: comparative evaluation of antioxidant, enzyme inhibition, and cytotoxic properties
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Anticancer activity of fluoxetine Janus dendrimer against cancer cells
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology
Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics
  • 31 Dec 2026
  • Artificial Cells, Nanomedicine, and Biotechnology

FAQs on Artificial Cells, Nanomedicine and Biotechnology